
-
ProKidney NASDAQ:PROK
Location: | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
1.215B
Cash
406.8M
Avg Qtr Burn
-31.89M
Short % of Float
17.06%
Insider Ownership
27.50%
Institutional Own.
44.68%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Rilparencel (REACT® Details Chronic kidney disease, Type 2 diabetes | Phase 3 Data readout | |
Rilparencel (REACT®) Details Chronic kidney disease, Type 2 diabetes | Phase 2 Update | |
Rilparencel (REACT® Details Chronic kidney disease, Diabetes | Phase 2 Update | |
Rilparencel (REACT® Details Chronic kidney disease, Type 2 diabetes | Failed Discontinued |